Keywords: million, velcade, marketing, deal, millennium, pharmaceuticals, health
J&J in $535 million Velcade marketing deal with Millennium Pharmaceuticals
Article | 07 July 2003
US health care major Johnson & Johnson has agreed a deal worth in excess of $535 million with biotechnology concern Millennium Pharmaceuticals, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
